Monitoring blood pressure continuously to improve hypertension management
Official title: OBPM_FORESEE2024: Evaluation of the Clinical Benefit of the Aktiia Blood Pressure Monitoring for Early Awareness of Hypertension and Prediction of Cardiovascular Risk in a Multi-ethnic European Population: an Observational Cohorts' Study
Run by Aktiia SA · NCT06670677 · Data updated 2026-11-12
This study is testing whether using a continuous blood pressure monitoring device can help people with high blood pressure manage their condition better over ten years.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 21 Years to 85 Years |
| Sex | All |
| Enrollment | 15000 (estimated) |
| Sponsor | Aktiia SA Industry-sponsored |
| Locations | 2 sites (Lausanne and 1 other locations) |
| Status | Recruiting |
| Started | May 12, 2025 |
| Main results expected | May 31, 2035 |
| Study ends | May 31, 2035 |
| Registry record updated | May 14, 2025 |
| Trial ID | NCT06670677 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 21 to 85 who are existing users of the Aktiia G1 device and reside in Switzerland, Germany, or the UK.
✕Probably not a fit
Patients with certain cardiac arrhythmias, severe peripheral perfusion issues, or other specified health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the clinical benefits of the Aktiia blood pressure monitoring device, focusing on its ability to provide continuous blood pressure readings and correlate these with various health and environmental factors. Participants, who are existing users of the Aktiia G1 device, will wear the device continuously for 10 years and complete online surveys every six months about their lifestyle and health. The study aims to gather extensive data to enhance hypertension management and predict cardiovascular risks based on continuous monitoring. The research includes two arms based on the smartphone operating system used by participants.
Why it matters
Potential benefit: If successful, this study could lead to improved management of hypertension and reduced cardiovascular risk for patients.
How similar studies have gone: While this approach is innovative in its use of continuous monitoring technology, similar studies have shown promise in managing hypertension through regular monitoring.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult subjects aged 21 to 85 years old 2. Subjects living in Switzerland, Germany or in the UK 3. Subjects that are: Aktiia users owning a smartphone with either iOS or Android operating system (ARMs 1 and 2); or Aktiia non-users owning a smartphone with iOS or Android operating system (ARM 3) 4. Subjects agreeing to follow the study procedures. Exclusion Criteria: 1. Subjects suffering from sustained cardiac arrhythmias that can lead to weak or unstable pressure pulses including resting tachycardia (heart rate at rest \> 120bpm) and atrial fibrillation; 2. Subjects suffering from pathologies that systematically reduce peripheral perfusion including Raynaud's disease, diabetes, renal dysfunctions (eGFR \< 30mL / min / 1.73 m2), untreated hyper-/ hypothyroidism, pheochromocytoma, or arteriovenous fistula; 3. Subjects suffering from polyneuropathy; 4. on pregnant women; 5. Subjects with damaged / injured skin at the wrists (for bracelet measurements) or at index fingers (for camera measurements) 6. Subjects with amputated index fingers (for camera measurements) or amputated upper limb; 7. Subjects below 21 years old and above 85 years old.
Where it's running
-
Fully remote study- no physical investigational site
Lausanne, Switzerland Recruiting -
Fully remote study- no physical investigational site
London, United Kingdom Recruiting
Study contacts
- Study coordinator: Pascale Vermare
- Email: pascale.vermare@aktiia.com
- Phone: +41 32 552 20 52
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using low-dose aspirin after preeclampsia to improve recovery
This study is testing if taking low-dose aspirin for six months after having preeclampsia can help new moms recover better by improving their blood pressure and blood vessel function.
-
Kidney and Heart Health in Adults with Type 2 Diabetes and CKD Treated with Semaglutide in China
This study tests whether semaglutide injections help kidney and heart health in adults with type 2 diabetes and chronic kidney disease.
-
IMB-guided health education to boost medication taking and blood pressure control in adults with hypertension
This study tests a health-literacy program based on Information-Motivation-Behavioral Skills to help adults with hypertension who don’t take their medicines regularly to take them more consistently and better control their blood pressure.
-
Renal Nerve Stimulation to Help Blood Pressure in AF and HFpEF
This study tests whether stimulating the kidneys with a catheter can safely lower blood pressure in adults with atrial fibrillation and HFpEF who also have hypertension.
-
Hypertension: Does Education Help Patients Manage Blood Pressure Better?
This study tests whether structured patient education improves blood pressure control and self-management in adults with hypertension who speak Turkish.
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.